Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
MORE SURPRISING DEVELOPMENTS for the anatomic pathology profession during the past three weeks! The impending $215 million acquisition ofĀ IMPATH, Inc. by Genzyme Corporation, announced on March 1, has the potential to send new ripples across the national market for oncology testing. What makes the GenzymeāIMPATH combination particularly fascinating was the $1 billion Genzyme paid, just …
CEO SUMMARY: Two unexpected things happened in IMPATHās Chapter 11 bankruptcy action. First, it attracted a buyer willing to pay the premium price of $215 million for its assets. Second, the buyer was not another laboratory company. Rather, it is a new entrant into the oncology diagnostics marketplace. This raises interesting questions as to Genzymeās …
CEO SUMMARY: Local pathology groups are advised to more closely track developments in the national market for oncology testing. Not only is big money targeting cancer testing, but a number of nimble, entrepreneurial start-up companies have begun to compete for specimens. Genzymeās acquisition of IMPATH validates this trend and promises to bring more change to …
UNINSURED PATIENT HOSPITAL CHARGES REDUCED AT HCA & TENET For-profit hospital ompanies moved swiftly to announce and publicize new policies for billing uninsured patients. These patients will see charges reduced to levels that are closer to what hospitals accept from HMOs and Medicare/Medicaid. HCA, which operates 166 acute care hospitals, disclosed in its 2003 year-end …
HCA, Tenet Healthcare, CMS, Abbott Labs, I-Stat, TheraSense Read More »
CEO SUMMARY: Do clinical laboratories in any of the worldās most developed countries have a performance advantage that makes them ābest of breed?ā Recently, a laboratory in the United States and a laboratory in the United Kingdom had the opportunity to evaluate their financial, productivity, and quality performance against each other. The results were unexpectedāand …
Side-by-Side Comparison: U.S. Lab Versus British Lab Read More »
BECAUSE OF ACQUISITIONS, there remain only four public laboratory companies which do substantial business in testing referred byĀ physiciansā offices. As public companies, their quarterly financial reports provide useful insights into the competitive marketplace for lab testing services. That is true of the year-end financial reports for both Quest Diagnostics Incorporated and Laboratory Corporation of America. …
Public Labsā Year-End Earnings Demonstrate Continued Growth Read More »
CEO SUMMARY: When the nationās leading laboratory administrators and pathologists gather in New Orleans on April 27- 28, they will get the best and latest developments in laboratory management. From Aetnaās National Medical Director to the former Chief of the Industry Guidance Branch of the OIG, the Ninth Annual Executive War College offers powerful information …
Useful Info at War College On Molecular, Lean, et al Read More »
Bar codes will soon be an essential element in most laboratories. Final regulations published on February 26 by the Food and Drug Administration (FDA) will take effect during the next two years. The FDA is requiring that prescription and over-the-counter drugs given to hospital patients have bar codes. Vaccines and certain blood and blood products …
“March 15, 2004 Intelligence: Late Breaking Lab News” Read More »
The Dark Report ā¢ 21806 Briarcliff Dr ā¢ Spicewood, TX 78669
Phone: 512-264-7103 ā¢ Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com
Ā© 2022 The Dark Report. All rights reserved.